Related Experiment Video
Updated: Mar 11, 2026
09:04
Low-Cost Single-Port LoCoSP Device for a Transcervical Approach in Minimally Invasive Transhiatal Esophagectomy
Published on: September 11, 2021
3.4K
Three-field lymph node dissection in treating the esophageal cancer
Qi-Xin Shang1, Long-Qi Chen1, Wei-Peng Hu1
1Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
Journal of Thoracic Disease
|November 22, 2016
Summary
Three-field lymphadenectomy offers improved survival for thoracic esophageal cancer patients, especially those with advanced lymph node metastasis. This approach is superior to two-field lymphadenectomy, with minimally invasive options showing promise.
Area of Science:
- Surgical Oncology
- Thoracic Surgery
- Gastrointestinal Oncology
Background:
- Controversy exists regarding the optimal lymphadenectomy extent for thoracic esophageal cancer.
- Evaluating the efficacy of 3-field versus 2-field lymphadenectomy is crucial for patient outcomes.
Approach:
- Comprehensive literature review of lymphadenectomy techniques in esophageal cancer.
- Analysis of studies comparing 3-field and 2-field lymphadenectomy, including minimally invasive surgery (MIE).
Key Points:
- 3-field lymphadenectomy demonstrates superior overall survival (OS) in esophageal cancer patients.
- It is particularly beneficial for tumors with cervical and/or upper mediastinal lymph node metastasis.
- Minimally invasive esophagectomy (MIE) and robotic-assisted surgery are safe and feasible alternatives.
Conclusions:
- 3-field lymphadenectomy is recommended for thoracic esophageal cancer, especially with advanced nodal disease.
- Further research is needed to refine techniques and assess the long-term benefits of minimally invasive approaches.
